Spain Fertility Services Market Overview,2030

Spain fertility service has become the top destination in Europe for fertility tourism, attracting thousands of international clients each year thanks to its progressive reproductive regulations, high-quality medical facilities, and easy access to assisted reproductive technologies (ART). A key aspect of its attractiveness is the legal provision for anonymous gamete donations, which stands in stark contrast to restrictions present in countries such as Germany, France, and the UK. This permissiveness allows clinics to have extensive and varied donor selections with short waiting periods, making Spain particularly appealing for egg donation, embryo adoption, and reciprocal IVF (ROPA) for same-sex partners. Since the 1980s, Spain has significantly opened up its fertility industry, with the 2006 Assisted Human Reproduction Law (LAHRT) broadening access for single women, lesbian couples, and foreign citizens. Currently, more than 55% of ART clients in Spain are from abroad, with clinics in cities like Madrid, Barcelona, and Alicante offering support in multiple languages and customized medical tourism options. In terms of techniques, ART in Spain encompasses IVF, ICSI, IUI, gamete donation, embryo transfers, and preimplantation genetic testing (PGT). These methods involve the handling of eggs, sperm, or embryos outside the human body to achieve pregnancy, often accompanied by individualized treatment plans and state-of-the-art diagnostics like ERA testing and assessments of genetic compatibility. Spain's research and development initiatives are also strong, with top clinics and research institutions investing in cryopreservation advancements. Modern cryobanks now facilitate the vitrification of oocytes, embryos, and gonadal tissues, allowing for fertility preservation among cancer survivors, transgender individuals, and those postponing parenthood for personal reasons. These cryobanks implement traceability features and AI-driven monitoring to guarantee the safety and viability of stored materials. With supportive laws, innovative laboratories, and a reputation for empathetic treatment, Spain maintains its status as a leader in fertility advancements and international reproductive services.

According to the research report, ""Spain Fertility Service Market Overview, 2030,"" published by Bonafide Research, the Spain Fertility Service market is anticipated to grow at 8.63% CAGR from 2025 to 2030. A significant factor influencing this field is the growth of banks for donor eggs and embryos, which provide short waiting periods, varied donor options, and sophisticated cryopreservation methods. These banks play a crucial role in attracting international clients, particularly from nations with stringent regulations on donations or limited availability of gametes. Clinics now provide unique donor matching, vitrified egg programs, and services for embryo adoption, all supported by strong traceability and quality assurance. Prominent businesses like IVI-RMA Global and Eugin are leaders in this market. IVI-RMA runs more than 70 facilities around the globe and is recognized for its impressive success rates, tailored treatment plans, and AI-assisted embryo selection. Eugin, which was recently acquired by IVI-RMA and GED Capital, remains a significant fertility brand known for its extensive reach and support for patients in multiple languages. Both organizations deliver a wide range of services, including IVF, ICSI, donor gametes, PGT, and fertility preservation, effectively catering to complicated situations and varied family compositions. Spain's reputation as the leading destination for fertility tourism in Europe is strengthened by its accommodating legal system. The Spanish Assisted Reproduction Law (Law 14/2006) permits treatments for single women and same-sex couples, facilitates anonymous gamete donations, and endorses methods such as ROPA and double donation. Adherence to these regulations is monitored by the National Commission on Assisted Human Reproduction along with the Ministry of Health, ensuring moral standards, donor vetting, and informed consent. With its blend of supportive laws, advanced technology, and focus on patient care, Spain continues to draw in thousands of patients from abroad each year, reinforcing its status as a frontrunner in reproductive healthcare.

Spain's fertility service sector by procedure is divided into IVF with ICSI, IUI, IVF without ICSI, Surrogacy and Others is characterized by progressive reproductive regulations and sophisticated clinical facilities, positioning it as a frontrunner in assisted reproductive technologies. In vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI) is the primary method, commonly utilized in both public and private medical centers due to its accuracy and high success rates, particularly beneficial in instances of male infertility or previous IVF failures. Donor programs, especially for egg and embryo donation, play a vital role in attracting individuals to Spain, bolstered by extensive, anonymous donor registries that offer quick access and a variety of genetic options. These initiatives operate under Law 14/2006, which enforces donor anonymity and altruism, providing ethical regulation while facilitating access for both local and international clients. Intrauterine insemination (IUI) is also readily available, catering to heterosexual partners, single women, and same-sex female couples in accordance with Spain's open legal standards. This treatment is frequently the initial approach for those with mild fertility issues and can be accessed through both public health services and private clinics, utilizing donor sperm from recognized banks. IVF without ICSI is accessible but used less often, mainly for couples exhibiting optimal sperm quality without prior fertilization problems. Conversely, surrogacy remains strictly illegal in Spain. New directives introduced in 2025 have further limited international surrogacy by prohibiting Spanish embassies from documenting births resulting from surrogacy outside the country, leading to legal challenges for prospective parents. Nonetheless, the fertility industry in Spain remains robust, thanks to its wide-ranging donor programs and high standards of care. Embryo donation, in particular, is becoming increasingly popular, as surplus embryos from families who have completed their families are offered anonymously to those desiring to become parents.

In Spain fertility service by cause of infertility is divided into Male Infertility and Female Infertility, issues with female infertility are the most common reproductive obstacle, primarily caused by postponed motherhood and various lifestyle elements. By 2024, more than 40% of women in Spain give birth past the age of 35, a point widely seen as the fertility limit. The typical age for women having their first child has risen to 32.6 years, with an increasing number of women becoming pregnant after 40, a time when natural conception rates fall to merely 20%. This age-related reduction in fertility is worsened by conditions such as endometriosis, PCOS, and lower ovarian reserves, leading to a greater need for assisted reproductive techniques (ART) like IVF and donor egg services. Fertility clinics throughout Spain now commonly provide tailored stimulation plans, frozen donor eggs, and embryo testing to tackle these issues, establishing Spain as a leading location for fertility preservation and treatments. Male infertility, which has often been overlooked in the past, has turned into a serious issue particularly for those traveling for fertility treatments. International patients, who are frequently older or have complicated reproductive backgrounds, come to Spanish clinics for superior diagnostics and procedures such as ICSI, TESE, and donor sperm choices. Research indicates that the quality of sperm has decreased, and Spain is no exception sperm concentration has fallen by 51%, along with declines in motility and morphology. Institutions like Instituto Bernabeu reveal that many patients have sperm counts that fall below ideal fertility levels, and the acceptance rates for donors have decreased by half in recent times due to more rigorous testing and lower quality. These trends collectively underline Spain's dual position as a provider of fertility care and a center for reproductive tourism.

Spain’s fertility care by end user is divided into Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes with private fertility clinics taking the lead in the international tourism sector, while public hospitals mainly cater to locals. Clinics like IVI-RMA, Eugin, Institut Marquès, and Barcelona IVF have established Spain as the top choice in Europe for cross-border reproductive services. These facilities provide multilingual assistance, reduced waiting times, and access to anonymous gamete donors elements that draw patients from nations with strict regulations or limited availability of ART. Their offerings encompass IVF, ICSI, donor egg and embryo programs, and preimplantation genetic testing (PGT), frequently combined with travel arrangements and concierge services. High rates of success and advanced laboratories further solidify Spain’s standing as a leader in fertility tourism. In contrast, public hospitals such as Hospital Clínic de Barcelona, La Paz in Madrid, and Gregorio Marañón concentrate on serving local patients under the universal healthcare framework of Spain. These facilities deliver state-supported ART services for qualified residents, including IVF and IUI, with access regulated by local health authorities. Their multidisciplinary teams combine expertise from gynecology, endocrinology, and reproductive counseling, ensuring continuous care for local populations. Surgical centers, often housed within university hospitals, carry out essential preparatory procedures vital for the success of ART. These include laparoscopic endometriosis treatment, fibroid extraction, and tubal surgeries, all of which can restore natural fertility or improve ART results. Spain’s surgical capabilities are highlighted through international conferences and partnerships in reproductive surgery. Institutions like University of Valencia, Universitat Autònoma de Barcelona, and University of Granada spearhead clinical investigations in ART, offering specialized master programs and conducting research in areas like embryology, cryobiology, and reproductive genetics.

Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• Fertility Services Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Procedure
• IVF with ICSI
• IUI
• IVF without ICSI
• Surrogacy
• Others

By Service
• Fresh Non-Donor
• Frozen Non-Donor
• Egg and Embryo Banking
• Fresh Donor
• Frozen Donor
By Cause of Infertility
• Male Infertility
• Female Infertility

By End User
• Fertility Clinics
• Hospitals
• Surgical Centers
• Clinical Research Institutes
Show more